BAGNARELLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 7.556
EU - Europa 3.634
AS - Asia 3.127
SA - Sud America 616
AF - Africa 214
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 15.159
Nazione #
US - Stati Uniti d'America 7.448
SG - Singapore 1.075
VN - Vietnam 674
UA - Ucraina 636
RU - Federazione Russa 629
BR - Brasile 471
CN - Cina 451
IT - Italia 422
DE - Germania 361
IE - Irlanda 355
SE - Svezia 306
HK - Hong Kong 257
DK - Danimarca 224
FR - Francia 217
TR - Turchia 216
FI - Finlandia 176
GB - Regno Unito 153
KR - Corea 125
CI - Costa d'Avorio 124
AR - Argentina 57
IN - India 57
MX - Messico 50
BD - Bangladesh 47
NL - Olanda 44
IQ - Iraq 40
ID - Indonesia 35
CA - Canada 34
ZA - Sudafrica 31
CO - Colombia 29
JP - Giappone 25
PK - Pakistan 22
PL - Polonia 22
BE - Belgio 20
MA - Marocco 20
ES - Italia 17
SA - Arabia Saudita 17
VE - Venezuela 17
AT - Austria 16
PH - Filippine 14
UZ - Uzbekistan 13
MY - Malesia 11
CL - Cile 10
EC - Ecuador 10
PY - Paraguay 9
TN - Tunisia 9
DZ - Algeria 6
JO - Giordania 6
TH - Thailandia 6
BO - Bolivia 5
EG - Egitto 5
EU - Europa 5
NP - Nepal 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BG - Bulgaria 4
CR - Costa Rica 4
JM - Giamaica 4
KZ - Kazakistan 4
LT - Lituania 4
RO - Romania 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KE - Kenya 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
BW - Botswana 2
BY - Bielorussia 2
CM - Camerun 2
HR - Croazia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LB - Libano 1
Totale 15.147
Città #
Ashburn 865
Des Moines 750
Chandler 700
Singapore 691
Jacksonville 642
Fairfield 479
Dublin 353
Boardman 334
Dallas 317
San Jose 312
Hong Kong 242
Wilmington 225
Woodbridge 205
Ho Chi Minh City 203
New York 193
Seattle 174
Houston 171
Hanoi 151
San Mateo 142
Lawrence 139
Princeton 139
Ann Arbor 131
Abidjan 124
Moscow 119
Lauterbourg 118
Cambridge 117
Civitanova Marche 96
Beijing 95
Los Angeles 95
The Dalles 83
Hefei 79
San Diego 67
Helsinki 52
Buffalo 48
Da Nang 47
Munich 46
São Paulo 39
London 35
Chicago 34
Redmond 33
Turin 32
Centro 31
Washington 30
Orem 29
Marche 27
Shanghai 21
Brussels 20
Haiphong 20
Norwalk 20
Rio de Janeiro 18
Santa Clara 18
Brooklyn 17
Tokyo 17
Warsaw 17
Bari 15
Council Bluffs 15
Frankfurt am Main 15
Johannesburg 15
Baghdad 14
Manchester 14
Chennai 13
Rome 13
Wuhan 13
Ancona 12
Mexico City 12
Phoenix 12
Amsterdam 11
Denver 11
Nuremberg 11
Stockholm 11
Tashkent 11
Thái Bình 11
Boston 10
Jakarta 10
Ninh Bình 10
Bogotá 9
Dhaka 9
Guangzhou 9
Iesi 9
Montreal 9
Biên Hòa 8
Kuala Lumpur 8
Milan 8
Mumbai 8
Columbus 7
Falls Church 7
Hanover 7
Pune 7
Querétaro 7
Salvador 7
Toronto 7
Turku 7
Vienna 7
Amman 6
Ankara 6
Asunción 6
Atlanta 6
Bắc Giang 6
Cape Town 6
Curitiba 6
Totale 9.643
Nome #
Antimicrobial Resistance: A Challenge for the Future 299
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 192
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 189
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 188
[Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells] 164
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. 161
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 160
[Acute respiratory infections caused by viruses, mycoplasmas, rickettsias and chlamydias with bronchial and pulmonary localization. 2 year's experience in the province of Ancona] 157
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 157
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 153
A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression. 152
Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site. 146
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 146
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 145
Survey of diagnostic and typing capacity for enterovirus infection in Italy and identification of two echovirus 30 outbreaks 145
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 143
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 143
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 141
Characterization of a Streptococcus suis tet(O/W/32/O)-carrying element transferable to major streptococcal pathogens. 141
Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance 140
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 139
Hepatitis E in a region of Italy: An emerging autochthonous infection? 139
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. 137
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 136
Abstract [Cross-over electrophoresis on cellulose acetate. A new method for rapid diagnosis of rotavirus infection] 134
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 133
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 133
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. 133
[Respiratory tract infections caused by viruses, Mycoplasma, Rickettsia and Chlamydia with bronchial and pulmonary localization] 131
[Hepatocarcinoma cell lines in vitro: binding of insulin] 128
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 128
Modulation of production of hepatitis B surface antigen by a human hepatoma cell line. 127
A human hepatoma cell line modulates its insulin receptors under different culture conditions. 127
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 125
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 125
Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. 124
Complement-fixation test for rotavirus detection: comparison and analysis of different methods to reduce anti-complementary activity of some specimens. 123
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 122
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 121
Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line. 121
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 121
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. 120
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. 119
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 119
Hepatitis e in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016 119
Human growth hormone induced modulation of hepatitis B virus (HBV) gene expression. 118
Diagnosis of human rotavirus infections: comparison of an electrophoretic method, a modified complement fixation test and electron microscopy for rotavirus detection. 117
Characterization of growth parameters of a human hepatoma cell line cultured under serum-free conditions. 117
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects. 116
Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. 116
[Pulmonitis caused by Coxiella burneti and Chlamydia psittaci. 2 years of research in Marche] 116
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 116
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. 115
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 114
Quantitation of HIV-1 genome copy number in semen and saliva. 113
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. 113
60. Hepeviridae 113
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 113
Differential response of the human hepatoma-derived cell line HA22T/VGH to polypeptide mitogens. 113
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 111
Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. 111
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 109
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 109
Insulin reduces HBsAg production by PLC/PRF/5 human hepatoma cell line. Brief report. 108
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. 108
Heterogeneity of West Nile virus genotype 1a in Italy, 2011. 108
Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report. 107
Quantitative molecular methods in virology. 107
Quantitative PCR and RT-PCR in virology. 107
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 107
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype. 107
Detection of hepatitis B virus DNA in serum using synthetic non-radioactive oligonucleotides. 107
Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. 106
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. 106
Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line. 105
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 103
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. 102
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 102
Are three generations of quantitative molecular methods sufficient in medical virology? Brief review 102
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 102
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 102
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. 101
Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity. Virology. 2002 Jul 20;299(1):1-7. 101
53. Togaviridae 101
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 101
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 100
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 99
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 98
Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013. 98
[Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma] 98
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 98
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors. 94
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 94
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 94
Weak cross-lineage neutralization by anti sars-cov-2 spike antibodies after natural infection or vaccination is rescued by repeated immunological stimulation 94
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 93
HIV avidity index performance using a modified fourth-generation immunoassay to detect recent HIV infections 93
Clearance of HIV-1 viraemia after seroconversion. 93
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 93
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 91
Totale 12.226
Categoria #
all - tutte 70.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 0 0 0 0 0 162 211 58
2021/20221.133 53 291 31 55 12 34 85 85 50 60 136 241
2022/20232.573 190 170 185 189 158 922 4 125 456 9 121 44
2023/20241.147 187 33 72 153 217 205 24 63 10 34 20 129
2024/20251.834 261 180 104 10 62 35 201 56 438 84 137 266
2025/20264.835 296 336 315 615 567 335 1.012 508 440 411 0 0
Totale 15.268